Leonardo, Narcisa T.

HRN: 28-64-55  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/05/2026
03/11/2026
IV
500mg
Q8
Cholelithiasis
Remove - Pending Acceptance
03/05/2026
CIPROFLOXACIN 2MG/ML, 100ML IV
03/05/2026
03/11/2026
IV
500mg
Q12
Cholelithiasis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: